New treatment options for the management of multiple myeloma

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new “preferred” regimens for transplant and nontransplant candidates, and have moved some formerly “preferred” regimens to the “other” category. Supportive care has improved outcomes for patients, and new treatments in combination have extended survival for patients with MM. Novel agents on the horizon are poised to raise the bar even further.

Original languageEnglish (US)
Pages (from-to)709-712
Number of pages4
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number5S
DOIs
StatePublished - May 1 2017

Fingerprint

Multiple Myeloma
Genetic Heterogeneity
Therapeutics
Guidelines
Transplants
Survival

ASJC Scopus subject areas

  • Oncology

Cite this

New treatment options for the management of multiple myeloma. / Kumar, Shaji K.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 5S, 01.05.2017, p. 709-712.

Research output: Contribution to journalArticle

@article{5f9a866fe33e402482c5fad8174096cb,
title = "New treatment options for the management of multiple myeloma",
abstract = "Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new “preferred” regimens for transplant and nontransplant candidates, and have moved some formerly “preferred” regimens to the “other” category. Supportive care has improved outcomes for patients, and new treatments in combination have extended survival for patients with MM. Novel agents on the horizon are poised to raise the bar even further.",
author = "Kumar, {Shaji K}",
year = "2017",
month = "5",
day = "1",
doi = "10.6004/jnccn.2017.0080",
language = "English (US)",
volume = "15",
pages = "709--712",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "5S",

}

TY - JOUR

T1 - New treatment options for the management of multiple myeloma

AU - Kumar, Shaji K

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new “preferred” regimens for transplant and nontransplant candidates, and have moved some formerly “preferred” regimens to the “other” category. Supportive care has improved outcomes for patients, and new treatments in combination have extended survival for patients with MM. Novel agents on the horizon are poised to raise the bar even further.

AB - Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new “preferred” regimens for transplant and nontransplant candidates, and have moved some formerly “preferred” regimens to the “other” category. Supportive care has improved outcomes for patients, and new treatments in combination have extended survival for patients with MM. Novel agents on the horizon are poised to raise the bar even further.

UR - http://www.scopus.com/inward/record.url?scp=85043380709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043380709&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0080

DO - 10.6004/jnccn.2017.0080

M3 - Article

VL - 15

SP - 709

EP - 712

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 5S

ER -